未登录

L

Ling Li

Sichuan University

H指数:34

被引数:5,582

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy of digital health technologies in patients with chronic pain: a protocol for a systematic review and meta-analysis

数字健康技术对慢性疼痛患者的疗效: 系统评价和荟萃分析的方案

Systematic Reviews

IF3.9

2026-01-070

OAAI

Inappropriate use of oncological 18F-FDG PET/CT scans: A cross-sectional analysis of prevalence and associated factors

肿瘤18F-FDG PET/CT扫描的不当使用：一项关于流行率和相关因素的横断面分析

CLINICAL IMAGING

IF1.5

2025-11-010

PRE

Association of skipping breakfast with depression: a systematic review and meta-analysis

早餐跳过与抑郁症的相关性：一项系统综述和荟萃分析

Frontiers in Psychiatry

IF3.2

2025-08-060

OA

IDEAL-Acu: A Methodological Framework for Evaluating the Effects of Acupuncture

IDEAL-Acu：一种评估针灸效果的方法学框架

bmj evidence based medicine

IF0

2025-06-090

OA

Nationwide analysis of routine clinical practices in the management of acute ischemic stroke patients in China

中国急性缺血性卒中患者管理中常规临床实践的国家层面分析

International Journal of Stroke

IF8.7

2025-05-120

PRE

Machine learning for identifying randomised controlled trials when conducting systematic reviews: Development and evaluation of its impact on practice

机器学习方法用于识别系统综述中的随机对照试验：开发及其对实践影响的评估

RESEARCH SYNTHESIS METHODS

IF6.1

2025-03-210

PRE

Prognostic nomogram for synchronous metastatic nasopharyngeal carcinoma: a retrospective multicentre study

同步转移性鼻咽癌的预后列线图: 一项回顾性多中心研究

RADIATION ONCOLOGY

IF3.2

2025-03-200

OAAI

Mechanisms of acupuncture at Zusanli (ST36) and its combinational acupoints for stress gastric ulcer based on the correlation between Zang-fu and acupoints

基于脏腑与腧穴相关性的足三里（ST36）及其配穴治疗应激性胃溃疡的机制研究

JOURNAL OF INTEGRATIVE MEDICINE-JIM

IF4

2025-01-010

PRE

Integration of non-randomized studies with randomized controlled trials in meta-analyses of clinical studies: a meta-epidemiological study on effect estimation of interventions

IF8.3

2024-12-020

OAAI

Risk of Asthma and Allergies in Children Delivered by Cesarean Section: A Comprehensive Systematic Review

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE

IF6.6

2024-10-012

PRE

Adaptive designs were primarily used but inadequately reported in early phase drug trials

BMC MEDICAL RESEARCH METHODOLOGY

IF3.4

2024-06-051

OAAI

Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM) : a multicentre, open-label, parallel-group, randomised, controlled, phase 3Btrial

IF88.5

2024-06-0120

PRE

Liu, Xu; Zhang, Yuan; Yang, Kun-Yu; Zhang, Ning; Jin, Feng; Zou, Guo-Rong; Zhu, Xiao-Dong; Xie, Fang-Yun; Liang, Xiao-Yu; Li, Wen-Fei; He, Zhen-Yu; Chen, Nian-Yong; Hu, Wei-Han; Wu, Hai-Jun; Shi, Mei; Zhou, Guan-Qun; Mao, Yan-Ping; Guo, Rui; Sun, Rui; Huang, Jing; Liang, Shao-Qiang; Wu, Wei-Li; Su, Zhen; Li, Ling; Ai, Ping; He, Yu-Xiang; Zang, Jian; Chen, Lei; Lin, Li; Huang, Shao Hui; Xu, Cheng; Lv, Jia-Wei; Li, Ying-Qing; Hong, Shu-Bin; Jie, Yu-Sheng; Li, Hao; Huang, Sai-Wei; Liang, Ye-Lin; Wang, Ya-Qin; Peng, Ying-Lin; Zhu, Jin-Han; Zang, Sheng-Bing; Liu, Song-Ran; Lin, Qing-Guang; Li, Hao-Jiang; Tian, Li; Liu, Li-Zhi; Zhao, Hong-Yun; Lin, Ai-Hua; Li, Ji-Bin; Liu, Na; Tang, Ling-Long; Chen, Yu-Pei; Sun, Ying; Ma, Jun

A systematic survey of adaptive trials shows substantial improvement in methods is needed

JOURNAL OF CLINICAL EPIDEMIOLOGY

IF5.2

2024-03-010

OAAI

Validation and impact of algorithms for identifying variables in observational studies of routinely collected data

JOURNAL OF CLINICAL EPIDEMIOLOGY

IF5.2

2024-02-011

PRE

Sample size calculations for randomized controlled trials with repeatedly measured continuous variables as primary outcomes need improvements: a cross-sectional study

JOURNAL OF CLINICAL EPIDEMIOLOGY

IF5.2

2024-02-010

PRE

Anti-tumor effect of PD-L1-targeting antagonistic aptamer-ASO delivery system with dual inhibitory function in immunotherapy

具有双重抑制功能的PD-L1-targeting拮抗适体-ASO递送系统在免疫治疗中的抗肿瘤作用

CELL CHEMICAL BIOLOGY

IF7.2

2023-11-019

OAAI

Efficacy and safety of Xian-Lian-Jie-Du optimization decoction as an adjuvant treatment for prevention of recurrence in patients with stage IIIB/IIIC colon cancer: study protocol for a multicentre, randomized controlled trial

BMC COMPLEMENTARY MEDICINE AND THERAPIES

IF3.4

2023-07-175

OAAI

Comparison of statistical methods for integrating real-world evidence in a rare events meta-analysis of randomized controlled trials

RESEARCH SYNTHESIS METHODS

IF6.1

2023-06-134

OA

Shenlingcao oral liquid for patients with non-small cell lung cancer receiving adjuvant chemotherapy after radical resection: A multicenter randomized controlled trial

IF8.3

2023-05-015

PRE

Data source profile reporting by studies that use routinely collected health data to explore the effects of drug treatment

数据源概况报告通过使用常规收集的健康数据来探索药物治疗效果的研究

BMC MEDICAL RESEARCH METHODOLOGY

IF3.4

2023-04-203

OAAI